✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-095 min read

GLP-1 Medications and Smoking: What Research Is Exploring About Nicotine Cravings

Early research is asking whether GLP-1 medications may influence nicotine cravings, and here is what that means if you are trying to quit smoking while losing weight.

A fresh-air walk along the coast

Can a GLP-1 help with smoking or nicotine cravings?

Research is exploring whether GLP-1 medications may influence cravings beyond food, including nicotine, but this is an early area of study and not an approved use. GLP-1 medications are prescribed for weight management, not for quitting smoking. If you want to quit, your physician can build a plan that fits your health and goals.

Why researchers are curious about cravings

GLP-1 medications work in part on appetite and the brain's reward signaling, which is why many people notice less interest in food and what some describe as quieter food noise. Because reward pathways overlap, researchers have begun asking whether these medications might also affect cravings for other substances, including nicotine and alcohol.

Ready to start?

$199 Skeptics' Trial, see if it works for you

One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.

Start the 30-day trial

It is important to keep this in perspective. Early reports and small studies are interesting, but they do not establish that a GLP-1 helps anyone stop smoking, and findings so far are preliminary. We do not overstate what is still being studied, and no one should start or stay on a GLP-1 expecting it to be a smoking treatment.

Quitting smoking while on a GLP-1

If you are already on a GLP-1 for weight loss and want to quit smoking, that is a goal worth supporting, since smoking and excess weight both affect long-term health. Quitting is also a good moment to lean on proven tools rather than waiting to see what a medication might do on its own.

How New Hope Weight Loss approaches it

At New Hope Weight Loss, Dr. Anjmun Sharma, MD provides physician-supervised, compounded GLP-1 weight management for patients in Costa Mesa and by telehealth. Our compounded semaglutide and tirzepatide are subject to patient-specific and location-specific dispensing-pharmacy verification and are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. We prescribe them for weight loss, and any decision about quitting smoking or adjusting medications is made with your physician.

Every patient starts with a $119 medical review, where Dr. Sharma looks at your full health picture, including smoking history, before recommending whether a GLP-1 plan is appropriate and how a quit-smoking goal fits into your broader care.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Take the free 2-minute quiz or call (657) 837-3342

Frequently asked questions

Does a GLP-1 help you quit smoking?

There is no proof that a GLP-1 helps people quit smoking. Research is exploring whether these medications affect nicotine cravings, but the findings are early and quitting smoking is not an approved use. Your physician can recommend evidence-based quit support.

Why do researchers think GLP-1 medications might affect cravings?

GLP-1 medications act partly on the brain's reward and appetite signaling, which overlaps with pathways involved in other cravings. That overlap is why researchers are studying nicotine and alcohol, though the science is still preliminary.

Can I take a GLP-1 just to stop smoking?

No. New Hope Weight Loss prescribes compounded GLP-1 medications for weight management, not as a smoking treatment. If quitting is your main goal, your physician can point you toward proven cessation tools.

Is it safe to quit smoking while on a GLP-1?

Many people pursue both goals, but any combination of a quit plan and your current medications should be reviewed by your physician first. Sharing your full health history helps build a safe, personalized plan.

Are the compounded GLP-1 medications at New Hope FDA-approved?

No. The compounded semaglutide and tirzepatide are subject to patient-specific and location-specific dispensing-pharmacy verification and are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Dr. Sharma supervises their use for weight management.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.